da Silva, IM, Plaza-Díaz, A, Ruiz-Ramos, J, Juanes-Borrego, A, Riera, P. The Role of Pharmacogenetic Biomarkers in Pain. Biomedicines. 2025; 13(8)DOI:10.3390/biomedicines13081935. PMID:40868188. IF:3.900(Q1/3D).

Arias-Alonso, L, Barragán-Brun, N, Elizondo-Alzola, U, Boldu-Minguell, A, Rocha-Calderón, CA, Niño-de-Guzmán, E, Santandreu, FM, Quesada-Carrasco, F, Ricci-Cabello, I, Gorrotxategi-Gorrotxategi, PJ, de la Poza-abad, M, Mas-Dalmau, G, Gibert-Agulló, A, González-Lama, J, Alonso-Coello, P. Development and assessment of an online communication skills course to optimise antibiotic prescribing for children in primary care. Bmc Primary Care. 2025; 26(1)DOI:10.1186/s12875-025-02919-6. PMID:40775754. IF:2.600(Q1/1D).

Obel, LM, Skovbo, JS, Diederichsen, ACP, Thomassen, M, Kjær, L, Larsen, MK, Knudsen, TA, Skov, V, Kruse, TA, Burton, M, Dembic, M, Wienecke, T, Sabater-Lleal, M, Gerke, O, Bruun, NE, Ellervik, C, Brabrand, M, Steffensen, FH, Frost, L, Lambrechtsen, J, Busk, M, Urbonaviciene, G, Egstrup, K, Karon, M, Feddersen, S, Rasmussen, LM, Hasselbalch, HC, Lindholt, JS. Aortic Aneurysm Risk and the Somatic JAK2 V617F Mutation: Insights From a Multicenter, Population-Based Cardiovascular Screening Study. CIRCULATION. 2025; 152(5)DOI:10.1161/CIRCULATIONAHA.125.074002. PMID:40464064. IF:38.600(Q1/1D).

Puig, N, Camps-Renom, P, Lambea, A, Guasch-Jiménez, M, Solé, A, Rives, J, Sanchez-Quesada, JL, Benitez, S. HDL from patients with recent ischemic stroke and carotid atherosclerosis shows less antioxidant enzymes and more inflammatory potential than patients with asymptomatic carotid atherosclerosis. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).

Lapeña, P, Urra, X, Llopis, J, Hernández-Meneses, M, Cuervo, G, Maisterra, O, Escrihuela-Vidal, F, Prats-Sánchez, L, Sáez, C, Olmos, C, Hernández-Fernández, F, Werner, M, de la Ossa, NP, Quintana, E, Moreno, A, Chamorro, A, Miró, JM. Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis. CLINICAL MICROBIOLOGY AND INFECTION. 2025; 31(8)DOI:10.1016/j.cmi.2025.02.008. PMID:39924109. IF:8.500(Q1/1D).

Kushlaf, H, Díaz-Manera, J, Bratkovic, D, Byrne, BJ, Claeys, KG, Clemens, PR, Dimachkie, MM, Kishnani, PS, Laforêt, P, Roberts, M, Schoser, B, Toscano, A, Castelli, J, Holdbrook, F, Das, SS, Goldman, M, Mozaffar, T. Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL. MUSCLE & NERVE. 2025; 72(2)DOI:10.1002/mus.28420. PMID:40342075. IF:3.100(Q2/4D).

Rodriguez-Antiguedad, J, Puig-Davi, A, Ruíz-Barrio, I, Pagonabarraga, J, Vázquez-Oliver, A, Horta-Barba, A, Kulisevsky, J, Martínez-Horta, S. CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline. Annals of Clinical and Translational Neurology. 2025; 12(8)DOI:10.1002/acn3.70075. PMID:40501082. IF:3.900(Q1/3D).

Corripio, I, Roldán, A. Targeting hallucinations in schizophrenia: Improving research translation into clinical practice. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 97DOI:10.1016/j.euroneuro.2025.05.005. PMID:40409235. IF:6.700(Q1/1D).